Terramed Alliance News Breast cancer patients 35 years old and younger have higher rates of their cancer returning after treatment than older women patients with the same stage of cancer, and their risk of recurrence is greatly impacted by the type of treatment they received, according to a March 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Previous studies have shown that younger breast cancer patients consistently have poorer outcomes than patients who develop the disease later in life, which can translate into lower rates of overall survival. While the reason for this is not known, it is suggested that breast cancer in younger patients is more biologically aggressive.
Researchers from the University of Texas M.D. Anderson Cancer Center in Houston sought to determine which form of breast cancer treatment – breast-conserving therapy, mastectomy alone or mastectomy with adjuvant radiation – better benefits younger women with either Stage I or Stage II breast cancer.
A total of 652 young women with breast cancer from 1973 to 2006 were studied, with 197 of the patients having received breast-conserving therapy, 237 having received a mastectomy and 234 having received mastectomy with adjuvant radiation. The study authors confirmed that younger breast cancer patients do have relatively high locoregional recurrence rates, but that patients with Stage II disease achieved the best locoregional control rates with mastectomy plus adjuvant radiation therapy. Patients with Stage I disease had similar outcomes with breast-conserving therapy and mastectomy, but adding chemotherapy to either treatment was beneficial.
“Locoregional recurrence after optimal breast cancer treatment in young women remains a significant problem,” Beth Beadle, M.D., Ph.D., a resident at M. D. Anderson and lead author of the study, said. “Our study hopefully will help radiation oncologists plan therapies for younger breast cancer patients, who have inferior outcomes compared to older patients, and generate new interest in prospective studies to evaluate the best treatment strategies for these young women.” American Society for Therapeutic Radiology and Oncology (2009). Younger Breast Cancer Patients Have Greater Chance Of Recurrence, Especially After Certain Treatments. ScienceDaily. Terramed Alliance is a non-profit charity organization dedicated to research, education and advocacy of breast cancer. One of the vision of Terramed Alliance is to provide this community and Internet users with a charity based research and education entity. Advocacy of breast cancer through education is vital to the reduction of this disease. For any requests and enquiries, please contact at us: cancer@terramedalliance.us www.terramedalliance.us
Terramed Alliance News Safe To Treat HER2-positive Breast Cancer - Terramed Alliance News Safe To Treat HER2-positive Breast Cancer With Trastuzumab And Adjuvant Radiation, Study FindsStandard adjuvant treatment for HER2-positive breast cancer patients, following pri .. (71 Views)
Terramed Alliance News Hope Street Kids joins CureSearch - Terramed Alliance News Strengthens National Efforts to Conquer Childhood CancerTo conquer childhood cancer, two leading pediatric cancer organizations, Hope Street Kids founded by former U.S. Congress .. (69 Views)
Terramed Alliance News Pink Ribbon Challenge - October is Breast Cancer Action Month and this year You can join The Terra Med Alliance Breast Cancer Foundation in taking Action against breast cancer. Join the fundraise in the The Pink Ribbon Chal .. (61 Views)
